Delta-Fly Pharma
4598.TTSE GROWTHPharmaceutical
Filed as Delta-Fly Pharma,Inc. (2022-06–2026-06)
Key numbers · FY ended 2026-03
Stock price4598 · View chart ↗
Open the price chart on TradingView.
Latest filings
Mon, Nov 9 · JST1 filing
11:495% STAKEDelta-Fly Pharma · Evo Fund + 1 joint holder · 19.39% → 18.34%−1.05ppMon, Nov 2 · JST1 filing
10:335% STAKEDelta-Fly Pharma · Evo Fund + 1 joint holder · 20.69% → 19.39%−1.30ppWed, Oct 21 · JST1 filing
10:335% STAKEDelta-Fly Pharma · Evo Fund + 1 joint holder · 22.55% → 21.47%−1.08ppThu, Oct 8 · JST1 filing
10:515% STAKEDelta-Fly Pharma · Evo Fund + 1 joint holder · 20.65% → 22.55%+1.90ppWed, Oct 7 · JST1 filing
11:065% STAKEDelta-Fly Pharma · Evo Fund + 1 joint holder · 22.71% → 20.65%−2.06ppMajor holders (5%+) · 4
| Holder | Stake |
|---|---|
| Evo Fund | 18.34% |
| SBI SECURITIES Co., Ltd. | 8.45% |
| Kiyoshi Eshima | 6.18% |
| Arcus Investment Limited Director/Executive Director Edward Cartwright | 5.20% |
Each holder's own ratio from its most recent large-shareholding report.